David G. Standaert, M.D., Ph.D.

Neurology University of Alabama, Birmingham, Birmingham, AL, United States 
Parkinson's disease
"David Standaert"
Mean distance: 14.28 (cluster 11)
Cross-listing: Neuropathology Tree


Sign in to add trainee
David Figge grad student UAB
Lindsey Stoyka grad student 2014- UAB
Aubrey Schonhoff grad student 2017- UAB
Gregory Williams grad student 2017- UAB
Shuwen Cao grad student 2012 UAB
Travis B. Lewis grad student 2012 UAB
Trent U. Steidinger grad student 2012 UAB
Mark Moehle grad student 2012-2015 UAB
Aaron Thome grad student 2011-2016 UAB
Chelsea Thompson Zimmerman grad student 2013-2017 UAB
Ashley Harms post-doc 2010- UAB
David Albers post-doc 1997-1999 Harvard Medical School
Sarah Augood post-doc 1997-1999 Harvard Medical School
Karsten Kueppenbender post-doc 1997-1999 Harvard Medical School
Anthone Dunah post-doc 1997-2000 Harvard Medical School
Jinhong Li post-doc 1999-2002 Harvard Medical School
Wendy Galpern post-doc 2002-2003 Harvard Medical School
Nutan Sharma post-doc 2001-2006 Harvard Medical School
Penelope Hallett post-doc 2002-2006 Harvard Medical School
Tom N. Grammatopoulos post-doc 2004-2006 Harvard Medical School
Anne Marie Wills post-doc 2005-2006 Harvard Medical School
Talene A. Yacoubian post-doc 2005-2007 Harvard Medical School
Qingmin Ruan post-doc 2006-2009 UAB (Cell Biology Tree)
Shaji Theodore post-doc 2006-2009 UAB
Michelle Gray post-doc 2008-2010 UAB
Karen Louise Jaunarajs post-doc 2011-2015 UAB
Craig Blackstone research scientist 1998-1999 Harvard Medical School
Michael G. Schlossmacher research scientist 1999-2000 Harvard Medical School (ID Tree)
Albert Hung research scientist 2000-2001 Harvard Medical School
Dimitri Krainc research scientist 2000-2001 Harvard Medical School
Clemens Scherzer research scientist 2001-2002 Harvard Medical School - Beth Israel Deaconess Medical Center
Alberto Leo research scientist 2002-2003 Harvard Medical School
Mee-Ohk Kim research scientist 2004-2006 Harvard Medical School
U. Shivraj Sohur research scientist 2004-2006 Harvard Medical School
Harrison Walker research scientist 2006-2008 UAB
Rohit Dhall research scientist 2007-2009 UAB
Victor Sung research scientist 2009-2011 UAB
Erik Roberson research scientist 2008-2012 UAB
Amy Amara research scientist 2009-2012 UAB
Ryan R. Walsh research scientist 2009-2012 UAB
Frank Skidmore research scientist 2013-2015 UAB
Pornpimol Anprasertporn research scientist 2014-2016 UAB
Neda Hidarilak research scientist 2014-2016 UAB
Benjamin McCullough research scientist 2015-2017 UAB
Sarah Perez research scientist 2015-2017 UAB
Marissa N. Dean research scientist 2016-2018 UAB
Jason L. Crowell research scientist 2017-2019 UAB
B. Luke Smelser research scientist 2017-2019 UAB
Juliana Coleman research scientist 2018-2020 UAB
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burack M, Aldred J, Zadikoff C, et al. (2019) Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats. Movement Disorders Clinical Practice. 6: 336-337
Espay AJ, Vizcarra JA, Marsili L, et al. (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337
Burack M, Aldred J, Zadikoff C, et al. (2018) Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners. Movement Disorders Clinical Practice. 5: 383-393
Williams GP, Schonhoff AM, Jurkuvenaite A, et al. (2018) Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Journal of Neuroinflammation. 15: 244
Szaflarski JP, Bebin EM, Cutter G, et al. (2018) Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy & Behavior : E&B
Fernandez HH, Boyd JT, Fung VSC, et al. (2018) Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society
Standaert DG, Boyd JT, Odin P, et al. (2018) Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics. Npj Parkinson's Disease. 4: 4
Standaert DG, Rodriguez RL, Slevin JT, et al. (2017) Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease. Movement Disorders Clinical Practice. 4: 829-837
Harms AS, Thome AD, Yan Z, et al. (2017) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Experimental Neurology
Amara AW, Walker HC, Joop A, et al. (2017) Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease. Movement Disorders Clinical Practice. 4: 183-190
See more...